BGF is a prominent growth capital investor operating across the United Kingdom and Ireland, providing patient funding to small and mid-sized enterprises.
The investment from BGF will support the digital agency's plans for strategic acquisitions and organic growth.
"We are extremely excited to be partnering with BGF through this investment. The Kagool team has a huge amount of energy for the next phase of growth, having excelled in recent years in our mission to be one of the best Sitecore agencies in the UK. BGF’s track record working with other technology entrepreneurs makes them the perfect match for the next phase of our journey."
Downing Ventures, BGF, Mercia, and Calculus Capital backed the Bedfordshire nanotechnology business in its latest round.
"We are delighted to be bringing such high-profile investors on board, who share our ambitious growth plans for the business. This significant investment is a strong endorsement of the MIPs technology, it will enable us to scale our operations and take the business to the next level. MIPs offer many advantages and provide solutions to enable new applications that push the limit of what was previously possible. This investment will enable us to rapidly expand our operations to service these opportunities and bring exciting new products to the market."
The investment round was led by Perwyn, BGF, MMC Ventures and Joe Wicks to support technology expansion and fulfilment capacity.
"We continue to be laser-focused on our vision to become the UK’s most-loved way to eat dinner. This additional investment is not only a validation of our track record, but it is also an endorsement of our strategic vision of the future which is rooted in investing in innovative technology to transform the way we search for, shop for, and cook our food."
The investment from BGF will support the rollout of the metra liver preservation system in the United States.
"This investment is key for 2 reasons. First, the funding will be critical in allowing us to execute our commercial plans in the US. Secondly, having BGF at the board table will ensure we leverage its impressive track record of successfully guiding growing businesses to achieve their full potential. Ultimately this is great news for all our stakeholders including current investors, employees and patients requiring a lifesaving organ transplant."
The menswear brand has raised £8.5m in a Series B round led by BGF to fund international expansion and product development.
"We believe that fit matters most"
